🚀 VC round data is live in beta, check it out!
Tectonic Therapeutic Valuation Multiples
Discover revenue and EBITDA valuation multiples for Tectonic Therapeutic and similar public comparables like Ocugen, Medigen Vaccine Biologics, MiMedx Group, Nxera Pharma and more.
Tectonic Therapeutic Overview
About Tectonic Therapeutic
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
Founded
2019
HQ
Employees
51
Website
Sectors
Financials (LTM)
EV
$324M
Tectonic Therapeutic Financials
Tectonic Therapeutic reported last 12-month revenue of —.
In the same LTM period, Tectonic Therapeutic generated — in gross profit and had net loss of ($81M).
Revenue (LTM)
Tectonic Therapeutic P&L
In the most recent fiscal year, Tectonic Therapeutic reported revenue of — and EBITDA of ($71M).
Tectonic Therapeutic expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA | — | XXX | ($71M) | XXX | XXX | XXX |
| Net Profit | ($81M) | XXX | ($74M) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Tectonic Therapeutic Stock Performance
Tectonic Therapeutic has current market cap of $577M, and enterprise value of $324M.
Market Cap Evolution
Tectonic Therapeutic's stock price is $30.72.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $324M | $577M | -1.2% | XXX | XXX | XXX | $-3.95 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialTectonic Therapeutic Valuation Multiples
Tectonic Therapeutic trades at (4.5x) EV/EBITDA.
Tectonic Therapeutic Financial Valuation Multiples
As of April 11, 2026, Tectonic Therapeutic has market cap of $577M and EV of $324M.
Equity research analysts estimate Tectonic Therapeutic's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Tectonic Therapeutic has a P/E ratio of (7.1x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $577M | XXX | $577M | XXX | XXX | XXX |
| EV (current) | $324M | XXX | $324M | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (4.5x) | XXX | XXX | XXX |
| EV/EBIT | (3.6x) | XXX | (3.9x) | XXX | XXX | XXX |
| P/E | (7.1x) | XXX | (7.8x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (5.4x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Tectonic Therapeutic Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Tectonic Therapeutic Margins & Growth Rates
Tectonic Therapeutic's revenue in the last fiscal year grew by —.
Tectonic Therapeutic's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $1.6M for the same period.
Tectonic Therapeutic Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Growth | — | XXX | 27% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $1.6M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Tectonic Therapeutic Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Ocugen | XXX | XXX | XXX | XXX | XXX | XXX |
| Medigen Vaccine Biologics | XXX | XXX | XXX | XXX | XXX | XXX |
| MiMedx Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Nxera Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Cormedix | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Tectonic Therapeutic M&A Activity
Tectonic Therapeutic acquired XXX companies to date.
Last acquisition by Tectonic Therapeutic was on XXXXXXXX, XXXXX. Tectonic Therapeutic acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Tectonic Therapeutic
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialTectonic Therapeutic Investment Activity
Tectonic Therapeutic invested in XXX companies to date.
Tectonic Therapeutic made its latest investment on XXXXXXXX, XXXXX. Tectonic Therapeutic invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Tectonic Therapeutic
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Tectonic Therapeutic
| When was Tectonic Therapeutic founded? | Tectonic Therapeutic was founded in 2019. |
| Where is Tectonic Therapeutic headquartered? | Tectonic Therapeutic is headquartered in United States. |
| How many employees does Tectonic Therapeutic have? | As of today, Tectonic Therapeutic has over 51 employees. |
| Who is the CEO of Tectonic Therapeutic? | Tectonic Therapeutic's CEO is Alise S. Reicin. |
| Is Tectonic Therapeutic publicly listed? | Yes, Tectonic Therapeutic is a public company listed on Nasdaq. |
| What is the stock symbol of Tectonic Therapeutic? | Tectonic Therapeutic trades under TECX ticker. |
| When did Tectonic Therapeutic go public? | Tectonic Therapeutic went public in 2024. |
| Who are competitors of Tectonic Therapeutic? | Tectonic Therapeutic main competitors are Ocugen, Medigen Vaccine Biologics, MiMedx Group, Nxera Pharma. |
| What is the current market cap of Tectonic Therapeutic? | Tectonic Therapeutic's current market cap is $577M. |
| Is Tectonic Therapeutic profitable? | No, Tectonic Therapeutic is not profitable. |
| What is the current net income of Tectonic Therapeutic? | Tectonic Therapeutic's last 12 months net income is ($81M). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.